Trial Profile
Safety and Immunogenicity Comparison of 2011-2012 High-Dose and Standard Intramuscular Influenza Virus Vaccines in Older Adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2012
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi Pasteur
- 30 Nov 2012 New trial record